Real-World Treatment Patterns and Clinical Outcomes Among Chinese Patients with Stage III NSCLC: The MOOREA Study
Targeted Oncology · 2026-05 · 21 (3) · 385-398
DOI: 10.1007/s11523-026-01217-0 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Targeted Oncology, online erschienen am 03.05.2026. Verfasst von Ligang Xing und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Shandong Cancer Hospital, No. 440 Jiyan Road, Jinan City, Shandong Province, China. xinglg@medmail.com.cn. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AstraZeneca China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, Shandong Cancer Hospital, No. 440 Jiyan Road, Jinan City, Shandong Province, China. xinglg@medmail.com.cn.
- Department of Radiation Oncology, Shandong Cancer Hospital, No. 440 Jiyan Road, Jinan City, Shandong Province, China.
- Department of Radiation Oncology, General Hospital of Ningxia Medical University, Yinchuan, China.
- Department of Respiratory Ward One, Shanxi Cancer Hospital, Taiyuan, China.
- Division of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
- Department of Medical Oncology, Sichuan Cancer Hospital and Institute, Chengdu, China.
Förderung
- AstraZeneca China
Zitieren
APA
Xing, L., Yu, J., Meng, X., Zhao, R., Yang, W., Guo, Y., Li, J., Fan, M., Xiao, C., Ren, Y., Dong, L., Lv, D., Zhao, L., Lin, Y., Zhang, X., Chen, L., Wang, Y., Zhang, Y., Zang, A., …, & Xiang, Z. L. (2026). Real-World Treatment Patterns and Clinical Outcomes Among Chinese Patients with Stage III NSCLC: The MOOREA Study. Targeted Oncology, 21(3), 385-398. https://doi.org/10.1007/s11523-026-01217-0
Vancouver
Xing L, Yu J, Meng X, Zhao R, Yang W, Guo Y, et al. Real-World Treatment Patterns and Clinical Outcomes Among Chinese Patients with Stage III NSCLC: The MOOREA Study. Targeted Oncology. 2026;21(3):385-398. doi:10.1007/s11523-026-01217-0
BibTeX
@article{Xing2026,
author = {Xing, Ligang and Yu, Jinming and Meng, Xiangjiao and Zhao, Ren and Yang, Weihua and Guo, Yubiao and Li, Juan and Fan, Min and Xiao, Chuangying and Ren, Yanping and Dong, Lihua and Lv, Dongqing and Zhao, Lujun and Lin, Yingcheng and Zhang, Xiaotao and Chen, Long and Wang, Ye and Zhang, Yuhui and Zang, Aimin and Cheng, Gregory and Liu, Anwen and Liang, Naixin and Lou, Baisong and Wang, Jun and Fu, Xiaolong and Shi, Anhui and Xu, Ning and Liu, Junfeng and Xiang, Zuo-Lin},
title = {Real-World Treatment Patterns and Clinical Outcomes Among Chinese Patients with Stage III NSCLC: The MOOREA Study},
journal = {Targeted Oncology},
year = {2026},
volume = {21},
number = {3},
pages = {385--398},
doi = {10.1007/s11523-026-01217-0}
}
EUVIMED